AMRX — Amneal Pharmaceuticals, Inc. Class A Common Stock

Founder-Led

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates AMRX Bullish with a Setup Score of 45, net conviction 50, actionability 41. How the Setup Score works →

Total Setup Score45
Directional BiasBullish
Net Conviction50
Actionability41 (in range)

Key signals behind this score

About Amneal Pharmaceuticals, Inc. Class A Common Stock

Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate and e… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$18.01
Market Cap$6.23B
Float186.1M
Shares Outstanding348.3M
P/E (Forward)6.30
P/E (TTM)38.09
Price/Sales (TTM)2.00
vs. Analyst Target+15.2% to analyst PT
Profit Margin5.05%
Operating Margin (TTM)18.34%
Revenue (TTM)$3.12B
Earnings Growth (YoY)157.10%
Dividend RateNone
Analyst Target Price$20.75 (4 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $1.99B $91.1M $628M $346M
2021 $2.09B $10.6M $769M $401M
2022 $2.21B -$130M $791M $440M
2023 $2.39B -$84.0M $864M $501M
2024 $2.79B -$117M $1.02B $440M
2025 $3.02B $72.1M $1.14B $604M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Sep 2025 $785M $2.4M
Dec 2025 $814M $35.1M
Mar 2026 $723M $62.3M
Jun 2026 $796M $57.7M

Ownership & Float

Insider Ownership52.2%
Institutional Ownership48.4%
Short Float4.5%
% of All Funds Holding3.47%
Number of Funds Holding305

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$17.77Near-term / short-term trend
Weekly40-Week SMA$14.34Medium-term trend
Weekly80-Week SMA$11.58Cyclical trend (business cycle)
Weekly200-Week SMA$7.66Secular trend (multi-year)
Monthly10-Month SMA$14.47Near-term monthly trend
Monthly20-Month SMA$11.57Medium-term monthly trend
Monthly40-Month SMA$8.69Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$13.10 support 1.19x 1 months ago
$7.80 support 1.09x 11 months ago
$7.40 support 1.26x 13 months ago

Historical Earnings Reactions (34 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.40% 0.08% 50.00% 5.36% -5.08%
1 Day 0.23% -0.98% 35.29% 19.05% -6.36%
1 Week -0.97% -1.17% 38.24% 15.18% -22.37%
2 Weeks 0.34% 0.06% 50.00% 28.27% -25.97%
1 Month 2.35% -0.23% 48.48% 36.36% -33.70%

Next earnings: October 18, 2026 (51 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan-0.8%50.0%8
Feb1.6%75.0%8
Mar-3.0%37.5%8
Apr0.4%37.5%8
May2.4%62.5%8
Jun2.6%33.3%9
Jul-1.4%55.6%9
Aug3.6%62.5%8
Sep-0.5%37.5%8
Oct1.2%75.0%8
Nov3.8%50.0%8
Dec6.2%62.5%8

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.52% 51.0% 392
Tuesday 0.35% 51.6% 430
Wednesday -0.34% 45.1% 426
Thursday -0.07% 44.6% 419
Friday 0.01% 47.8% 418

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 48.4%

Insider Transactions — Smart Summary

Total insider ownership: 52.2%

Founder-led management: Chirag Patel (Co-Chief Executive Officer and President, Director), Chintu Patel (Co-Chief Executive Officer, Director)

12-Month Insider Activity Summary

Total Filings7
Net Value-$7.5M
Net Shares Change-539,835
% of Float-0.3%
C-Suite Filings3
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
Shah Nikita Executive Vice President -$3.8M 2 2 sell
Daly Jason B. EVP, Chief Legal Officer -$3.8M 1 1 sell
Kiely John -$1.2M 2 2 sell
Nark Ted C -$586,000 1 1 sell
Autor Deborah M. -$450,557.86 1 1 sell

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2026-08-13 – 2026-08-14 3 3 -$7.2M 2 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-08-13 Shah Nikita Executive Vice President -$2.6M Transaction at $17.51, now +2.9%
2026-08-13 Daly Jason B. EVP, Chief Legal Officer -$3.8M Transaction at $17.41, now +3.5%
2026-08-14 Kiely John -$882,000 Transaction at $17.64, now +2.1%
2026-05-12 Autor Deborah M. -$450,557.86 Transaction at $12.94, now +39.2%
2025-11-19 Nark Ted C -$586,000 Transaction at $11.72, now +53.7%
2025-08-28 Kiely John -$295,360 Transaction at $9.23, now +95.1%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for AMRX on Trend Edge →